Third Harmonic Bio, Inc.

General ticker "THRD" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $399.6M (TTM average)

Third Harmonic Bio, Inc. follows the US Stock Market performance with the rate: 3.9%.

Estimated limits based on current volatility of 0.5%: low 5.42$, high 5.47$

Factors to consider:

  • Current price 24.2% below estimated low
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [7.16$, 13.56$]
  • 2025-12-31 to 2026-12-31 estimated range: [5.93$, 11.51$]

Financial Metrics affecting the THRD estimates:

  • Negative: Non-GAAP EPS, $ of -1.08 <= 0.05
  • Negative: Operating cash flow per share per price, % of -6.68 <= 1.99
  • Negative: Industry operating cash flow per share per price (median), % of -20.97 <= 2.94
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term THRD quotes

Long-term THRD plot with estimates

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $0.00MM $0.00MM $117.74MM
Operating Expenses $37.71MM $43.95MM $58.87MM
Operating Income $-37.71MM $-43.95MM $58.87MM
Non-Operating Income $2.55MM $13.13MM $-13.40MM
R&D Expense $24.41MM $23.96MM $36.50MM
Income(Loss) $-35.16MM $-30.82MM $45.47MM
Profit(Loss)* $-37.71MM $-30.82MM $136.41MM
Stockholders Equity $289.07MM $269.08MM $285.15MM
Assets $298.68MM $277.71MM $294.61MM
Operating Cash Flow $-34.92MM $-20.43MM $-34.50MM
Capital expenditure $0.04MM $0.17MM $0.01MM
Investing Cash Flow $-0.04MM $-0.17MM $-0.01MM
Financing Cash Flow $195.99MM $0.80MM $50.51MM
Earnings Per Share** $-0.96 $-0.78 $3.27

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.